Ibrutinib plus Venetoclax May Be Effective in Mantle-Cell Lymphoma [Research Watch]

Ibrutinib plus venetoclax is superior to monotherapy in patients with mantle-cell lymphoma.

from Cancer via ola Kala on Inoreader https://ift.tt/2IziRN1
via IFTTT